An evaluation of regulatory and commercial barriers to stratified medicine development and adoption.
about
A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion DiagnosticsPharmacogenetic Markers of Drug Efficacy and Toxicity.On the readiness of physicians for pharmacogenomics testing: an empirical assessment.Key elements of metabolomics in the study of biomarkers of diabetes.
P2860
An evaluation of regulatory and commercial barriers to stratified medicine development and adoption.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
An evaluation of regulatory an ...... cine development and adoption.
@en
type
label
An evaluation of regulatory an ...... cine development and adoption.
@en
prefLabel
An evaluation of regulatory an ...... cine development and adoption.
@en
P2093
P2860
P356
P1476
An evaluation of regulatory an ...... cine development and adoption.
@en
P2093
A Morrison
D A Brindley
N A Meadows
R W Barker
P2860
P2888
P356
10.1038/TPJ.2014.51
P577
2014-10-07T00:00:00Z
P6179
1034800280